E2E Pharmacovigilance Planning
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 1, 2005
April 20, 2020
89ea2b55-7e7d-4a99-9e7f-9aac73abf09b
Related Documents
Premarketing Risk Assessment: Guidance for Industry
Guidance DocumentMarch 29, 2005Center for Drug Evaluation and Research
Q1E Evaluation of Stability Data
Guidance DocumentJune 8, 2004Center for Drug Evaluation and Research
Q1A(R2) Stability Testing of New Drug Substances and Products
Guidance DocumentNovember 21, 2003Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.